In vitro inflammation inhibition model based on semi-continuous toll-like receptor biosensing

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Jeon, Jin Woo ^a   Ha, Un Hwan ^a   Paek, Se Hwan ^a  

^a Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LYSATE; CAFFEIC ACID PHENETHYL ESTER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PARACETAMOL; SALICYLATE SODIUM; TOLL LIKE RECEPTOR 1; ANTIINFLAMMATORY AGENT; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOLOGICAL MODEL; BIOLOGICAL MONITORING; CELL STRAIN; CELL STRAIN A549; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFICACY; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; MAMMAL CELL; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; ANIMAL; DRUG SCREENING; GENETIC PROCEDURES; HELA CELL LINE; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PROCEDURES; SHIGELLA SONNEI; VIBRIO;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOSENSING TECHNIQUES; DRUG EVALUATION, PRECLINICAL; HELA CELLS; HUMANS; INFLAMMATION; MICE; PSEUDOMONAS AERUGINOSA; SHIGELLA SONNEI; SODIUM SALICYLATE; TOLL-LIKE RECEPTORS; VIBRIO;

EID: 84929941451     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105212     Document Type: Article

References (56)

1. Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE (2007) Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin Exp Immunol 147: 227-235. (Pubitemid 46095999)
2. Weiss U (2008) Inflammation. Nature 454: 427.
3. Nathan C (2002) Points of control in inflammation. Nature 420: 846-852.
4. Ghaemmaghami AM, Hancock MJ, Harrington H, Kaji H, Khademhosseini A (2012) Biomimetic tissues on a chip for drug discovery. Drug Discov Today 17: 173-181.
5. Snyder DS (1976) Effect of topical indomethacin on UVR-induced redness and prostaglandin E levels in sunburned guinea pig skin. Prostaglandins 11: 631-643.
6. Intahphuak S, Panthong A, Kanjanapothi D, Taesotikul T, Krachangchaeng C, et al. (2004) Anti-inflammatory and analgesic activities of Mallotus spodocarpus Airy shaw. J Ethnopharmacol 90: 69-72. (Pubitemid 38091688)
7. Xu Z, Zhou J, Cai J, Zhu Z, Sun X, et al. (2012) Anti-inflammation effects of hydrogen saline in LPS activated macrophages and carrageenan induced paw oedema. J Inflamm (Lond) 9: 2.
8. Lan T, Kandimalla ER, Yu D, Bhagat L, Li Y, et al. (2007) Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8. Proc Natl Acad Sci U S A 104: 13750-13755. (Pubitemid 350003392)
9. Panter G, Kuznik A, Jerala R (2009) Therapeutic applications of nucleic acids as ligands for Toll-like receptors. Curr Opin Mol Ther 11: 133-145.
10. Singh AK, Parashar A, Singh AK, Singh R (2013) Pre-natal/juvenile chlorpyrifos exposure associated with immunotoxicity in adulthood in Swiss albino mice. J Immunotoxicol 10: 141-149.
11. Hennessy EJ, Parker AE, O'Neill LA (2010) Targeting Toll-like receptors: emerging therapeutics? Nat Rev Drug Discov 9: 293-307.
12. Ehlers M, Ravetch JV (2007) Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance. Trends Immunol 28: 74-79. (Pubitemid 46176735)
13. Meneghin A, Hogaboam CM (2007) Infectious disease, the innate immune response, and fibrosis. J Clin Invest 117: 530-538. (Pubitemid 46348507)
14. Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, et al. (2010) Reconstituting organ-level lung functions on a chip. Science 328: 1662-1668.
15. Leung MC, Williams PL, Benedetto A, Au C, Helmcke KJ, et al. (2008) Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicol Sci 106: 5-28.
16. Irazoqui JE, Troemel ER, Feinbaum RL, Luhachack LG, Cezairliyan BO, et al. (2010) Distinct pathogenesis and host responses during infection of C. elegans by P. aeruginosa and S. aureus. PLoS Pathog 6: e1000982.
17. Gosai SJ, Kwak JH, Luke CJ, Long OS, King DE, et al. (2010) Automated high-content live animal drug screening using C. elegans expressing the aggregation prone serpin alpha1-antitrypsin Z. PLoS One 5: e15460.
18. Medzhitov R (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1: 135-145.
19. Ospelt C, Gay S (2010) TLRs and chronic inflammation. Int J Biochem Cell Biol 42: 495-505.
20. Kaplan AP, Joseph K, Silverberg M (2002) Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol 109: 195-209. (Pubitemid 34158283)
21. Margolius HS (1995) Theodore Cooper Memorial Lecture. Kallikreins and kinins. Some unanswered questions about system characteristics and roles in human disease. Hypertension 26: 221-229.
22. Kopp E, Ghosh S (1994) Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265: 956-959.
23. Seabrook GR, Bowery BJ, Heavens R, Brown N, Ford H, et al. (1997) Expression of B1 and B2 bradykinin receptor mRNA and their functional roles in sympathetic ganglia and sensory dorsal root ganglia neurones from wild-type and B2 receptor knockout mice. Neuropharmacology 36: 1009-1017. (Pubitemid 27300131)
24. Sabourin T, Morissette G, Bouthillier J, Levesque L, Marceau F (2002) Expression of kinin B(1) receptor in fresh or cultured rabbit aortic smooth muscle: role of NF-kappa B. Am J Physiol Heart Circ Physiol 283: H227-237. (Pubitemid 34705344)
25. Raymond P, Drapeau G, Raut R, Audet R, Marceau F, et al. (1995) Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation. J Immunol Methods 180: 247-257.
26. Cugno M, Agostoni P, Brunner HR, Gardinali M, Agostoni A, et al. (2000) Plasma bradykinin levels in human chronic congestive heart failure. Clin Sci (Lond) 99: 461-466.
27. Granstrom E, Hamberg M, Hansson G, Kindahl H (1980) Chemical instability of 15-keto-13,14-dihydro-PGE2: the reason for low assay reliability. Prostaglandins 19: 933-957. (Pubitemid 10013224)
28. Fitzpatrick FA, Aguirre R, Pike JE, Lincoln FH (1980) The stability of 13,14-dihydro-15 keto-PGE2. Prostaglandins 19: 917-931.
29. Stamme C, Walsh E, Wright JR (2000) Surfactant protein A differentially regulates IFN-gamma- and LPS-induced nitrite production by rat alveolar macrophages. Am J Respir Cell Mol Biol 23: 772-779. (Pubitemid 32013269)
30. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr (1995) Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270: 283-286.
31. Prado GN, Taylor L, Zhou X, Ricupero D, Mierke DF, et al. (2002) Mechanisms regulating the expression, self-maintenance, and signaling-function of the bradykinin B2 and B1 receptors. J Cell Physiol 193: 275-286. (Pubitemid 35265948)
32. Verstrepen L, Bekaert T, Chau TL, Tavernier J, Chariot A, et al. (2008) TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell Mol Life Sci 65: 2964-2978.
33. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, et al. (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. Faseb J 9: 899-909.
34. Cho IH, Jeon JW, Paek SH, Kim DH, Shin HS, et al. (2012) Toll-like receptor-based immuno-analysis of pathogenic microorganisms. Anal Chem 84: 9713-9720.
35. Jeon JW, Cho IH, Ha UH, Seo SK, Paek SH (2014) Chemiluminometric Immuno-Analysis of Innate Immune Response against Repetitive Bacterial Stimulations for the Same Mammalian Cells. SCI REP-UK: Accepted.
36. Yin MJ, Yamamoto Y, Gaynor RB (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396: 77-80. (Pubitemid 28520452)
37. Hertzberg RP, Pope AJ (2000) High-throughput screening: new technology for the 21st century. Curr Opin Chem Biol 4: 445-451. (Pubitemid 30621048)
38. Shin HS, Ha UH (2011) Up-regulation of bradykinin B2 receptor by Pseudomonas aeruginosa via the NF-kappaB pathway. Curr Microbiol 63: 138-144.
39. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, et al. (1973) In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51: 1417-1423.
40. Shin HS, Lee JH, Paek SH, Jung YW, Ha UH (2013) Pseudomonas aeruginosa-dependent upregulation of TLR2 influences host responses to a secondary Staphylococcus aureus infection. Pathog Dis 69: 149-156.
41. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231: 232-235.
42. Bellosillo B, Pique M, Barragan M, Castano E, Villamor N, et al. (1998) Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 92: 1406-1414. (Pubitemid 28369055)
43. Mousavi SA, Malerod L, Berg T, Kjeken R (2004) Clathrin-dependent endocytosis. Biochem J 377: 1-16. (Pubitemid 38114427)
44. Natarajan K, Singh S, Burke TR Jr, Grunberger D, Aggarwal BB (1996) Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci U S A 93: 9090-9095. (Pubitemid 26282023)
45. Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, et al. (2001) Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 345: 1809-1817.
46. Hinz B, Cheremina O, Brune K (2008) Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J 22: 383-390. (Pubitemid 351225574)
47. Tian H, Ip L, Luo H, Chang DC, Luo KQ (2007) A high throughput drug screen based on fluorescence resonance energy transfer (FRET) for anticancer activity of compounds from herbal medicine. Br J Pharmacol 150: 321-334. (Pubitemid 46221041)
48. Chyka PA, Erdman AR, Christianson G, Wax PM, Booze LL, et al. (2007) Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila) 45: 95-131.
49. Prescott LF, Balali-Mood M, Critchley JA, Johnstone AF, Proudfoot AT (1982) Diuresis or urinary alkalinisation for salicylate poisoning? Br Med J (Clin Res Ed) 285: 1383-1386. (Pubitemid 13230010)
50. Huttunen K, Hyvarinen A, Nevalainen A, Komulainen H, Hirvonen MR (2003) Production of proinflammatory mediators by indoor air bacteria and fungal spores in mouse and human cell lines. Environ Health Perspect 111: 85-92.
51. Vandooren J, Van den Steen PE, Opdenakker G (2013) Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade. Crit Rev Biochem Mol Biol 48: 222-272.
52. Stryer L (1978) Fluorescence energy transfer as a spectroscopic ruler. Annu Rev Biochem 47: 819-846.
53. Vazquez de Lara LG, Umstead TM, Davis SE, Phelps DS (2003) Surfactant protein A increases matrix metalloproteinase-9 production by THP-1 cells. Am J Physiol Lung Cell Mol Physiol 285: L899-906. (Pubitemid 37158837)
54. Wu SH, Lee KL, Chiou A, Cheng X, Wei PK (2013) Optofluidic platform for real-time monitoring of live cell secretory activities using Fano resonance in gold nanoslits. Small 9: 3532-3540.
55. HogenEsch H, Nikitin AY (2012) Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal models. J Control Release 164: 183-186.
56. Liu Q, Wu C, Cai H, Hu N, Zhou J, et al. (2014) Cell-Based Biosensors and Their Application in Biomedicine. Chem Rev.